NRBP1 promotes malignant phenotypes of glioblastoma by regulating PI3K/Akt activation.
Anli ZhangShichao PengSibai SunShan YeYe ZhaoQiang WuPublished in: Cancer medicine (2024)
This study shows that NRBP1 promotes malignant phenotypes in GBM by activating PI3K/Akt pathway. Hence, it can function as both a predictive indicator and a new target for therapies in GBM treatment.